Latest News
GRAIL, Inc.
- GRAIL Inc Estimates – FWB:NL0
- 5 doctors weigh in on the promise, limitations of Grail’s multicancer test
- Watch Biocon Chair: AI in Clinical Trials Is the Holy Grail
- Opinion | The Holy Grail Of AI Is Trust And India Has The Edge
- Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
- Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
- AI solves a ‘holy grail’ problem from probability theory
- This Stock, Up Almost 70%, May Have Found Cancer's Holy 'Grail'
- 3 Reasons to Buy Grail (GRAL) Hand Over Fist in October
- Lightning Round: Grail can go higher, says Jim Cramer
- Grail multicancer detection test wins FDA advisers’ backing
- Grail survives adcomm vote as it awaits FDA decision for cancer blood test
Headlines from the last 30 days, linking to the original publishers. See all market news →